PT2785710T - Benzimidazóis e benzopirazóis substituídos como antagonistas de ccr(4) - Google Patents
Benzimidazóis e benzopirazóis substituídos como antagonistas de ccr(4)Info
- Publication number
- PT2785710T PT2785710T PT127985745T PT12798574T PT2785710T PT 2785710 T PT2785710 T PT 2785710T PT 127985745 T PT127985745 T PT 127985745T PT 12798574 T PT12798574 T PT 12798574T PT 2785710 T PT2785710 T PT 2785710T
- Authority
- PT
- Portugal
- Prior art keywords
- benzopyrazoles
- ccr
- antagonists
- substituted benzimidazoles
- benzimidazoles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161565973P | 2011-12-01 | 2011-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2785710T true PT2785710T (pt) | 2017-12-18 |
Family
ID=47324474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT127985745T PT2785710T (pt) | 2011-12-01 | 2012-11-30 | Benzimidazóis e benzopirazóis substituídos como antagonistas de ccr(4) |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US8685959B2 (pt) |
| EP (1) | EP2785710B1 (pt) |
| JP (1) | JP6141863B2 (pt) |
| KR (1) | KR102031846B1 (pt) |
| CN (1) | CN103974950B (pt) |
| AU (1) | AU2012345779B2 (pt) |
| BR (1) | BR112014013150A2 (pt) |
| CA (1) | CA2856831C (pt) |
| DK (1) | DK2785710T3 (pt) |
| ES (1) | ES2648340T3 (pt) |
| HK (1) | HK1202866A1 (pt) |
| MX (1) | MX354955B (pt) |
| PT (1) | PT2785710T (pt) |
| WO (1) | WO2013082429A1 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9361365B2 (en) * | 2008-05-01 | 2016-06-07 | Primal Fusion Inc. | Methods and apparatus for searching of content using semantic synthesis |
| ES2648340T3 (es) | 2011-12-01 | 2018-01-02 | Chemocentryx, Inc. | Benzoimidazoles y benzopirazoles substituidos como antagonistas de CCR(4) |
| KR20150096794A (ko) | 2012-12-21 | 2015-08-25 | 제니쓰 에피제네틱스 코포레이션 | 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물 |
| WO2014175370A1 (ja) * | 2013-04-25 | 2014-10-30 | 塩野義製薬株式会社 | ピロリジン誘導体およびそれらを含有する医薬組成物 |
| ES2806135T3 (es) * | 2013-06-21 | 2021-02-16 | Zenith Epigenetics Ltd | Nuevos inhibidores de bromodominios bicíclicos |
| JP6461118B2 (ja) | 2013-06-21 | 2019-01-30 | ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． | ブロモドメイン阻害剤としての新規の置換された二環式化合物 |
| US9855271B2 (en) | 2013-07-31 | 2018-01-02 | Zenith Epigenetics Ltd. | Quinazolinones as bromodomain inhibitors |
| GB201321740D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| EP3227280B1 (en) | 2014-12-01 | 2019-04-24 | Zenith Epigenetics Ltd. | Substituted pyridines as bromodomain inhibitors |
| US10710992B2 (en) | 2014-12-01 | 2020-07-14 | Zenith Epigenetics Ltd. | Substituted pyridinones as bromodomain inhibitors |
| WO2016092375A1 (en) | 2014-12-11 | 2016-06-16 | Zenith Epigenetics Corp. | Substituted heterocycles as bromodomain inhibitors |
| CN107406438B (zh) | 2014-12-17 | 2021-05-14 | 恒翼生物医药科技(上海)有限公司 | 溴结构域的抑制剂 |
| CN104622874B (zh) * | 2015-02-15 | 2017-12-26 | 中国科学院生物物理研究所 | Ccr4拮抗剂在抑制癌生长及转移中的应用 |
| RU2768827C2 (ru) * | 2016-07-29 | 2022-03-24 | ФЛЭкс БАЙО, ИНК. | Модуляторы хемокинового рецептора и их применение |
| US10246462B2 (en) | 2016-09-09 | 2019-04-02 | Flx Bio, Inc. | Chemokine receptor modulators and uses thereof |
| US11459308B2 (en) | 2016-12-05 | 2022-10-04 | Microbiotix, Inc. | Broad spectrum inhibitors of filoviruses |
| WO2018187509A1 (en) * | 2017-04-04 | 2018-10-11 | Flx Bio, Inc. | Heterocyclic compounds as chemokine receptor modulators |
| US10800760B2 (en) | 2017-05-31 | 2020-10-13 | Nantbio, Inc. | Trk inhibition |
| KR20200104291A (ko) * | 2017-11-06 | 2020-09-03 | 랩트 테라퓨틱스, 인크. | 항암제 |
| RU2020128176A (ru) | 2018-01-26 | 2022-03-02 | Рапт Терапьютикс, Инк. | Модуляторы рецепторов хемокинов и их применение |
| CA3145303A1 (en) | 2019-07-10 | 2021-01-14 | Chemocentryx, Inc. | Indanes as pd-l1 inhibitors |
| WO2023143194A1 (zh) * | 2022-01-25 | 2023-08-03 | 瑞石生物医药有限公司 | 一种ccr4小分子拮抗剂及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| WO1998005327A1 (en) | 1996-08-05 | 1998-02-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted aromatic compounds |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| KR100912146B1 (ko) * | 2004-10-27 | 2009-08-14 | 에프. 호프만-라 로슈 아게 | 인돌 또는 벤즈이미다졸 유도체 |
| MX2007010068A (es) * | 2005-02-16 | 2007-10-10 | Schering Corp | Piperazino-piperidinas con actividad antagonista de cxcr3. |
| US7790884B2 (en) * | 2006-03-24 | 2010-09-07 | Astellas Pharma Inc. | Acylaminopiperidine compound |
| JP2010208945A (ja) * | 2007-06-01 | 2010-09-24 | Mitsubishi Tanabe Pharma Corp | 複素環化合物 |
| WO2010121046A1 (en) * | 2009-04-17 | 2010-10-21 | Janssen Pharmaceutica Nv | 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2 |
| ES2648340T3 (es) | 2011-12-01 | 2018-01-02 | Chemocentryx, Inc. | Benzoimidazoles y benzopirazoles substituidos como antagonistas de CCR(4) |
-
2012
- 2012-11-30 ES ES12798574.5T patent/ES2648340T3/es active Active
- 2012-11-30 CA CA2856831A patent/CA2856831C/en active Active
- 2012-11-30 PT PT127985745T patent/PT2785710T/pt unknown
- 2012-11-30 DK DK12798574.5T patent/DK2785710T3/en active
- 2012-11-30 BR BR112014013150A patent/BR112014013150A2/pt not_active IP Right Cessation
- 2012-11-30 CN CN201280058945.8A patent/CN103974950B/zh active Active
- 2012-11-30 EP EP12798574.5A patent/EP2785710B1/en active Active
- 2012-11-30 US US13/691,589 patent/US8685959B2/en active Active
- 2012-11-30 AU AU2012345779A patent/AU2012345779B2/en active Active
- 2012-11-30 JP JP2014544923A patent/JP6141863B2/ja active Active
- 2012-11-30 KR KR1020147018282A patent/KR102031846B1/ko active IP Right Grant
- 2012-11-30 WO PCT/US2012/067299 patent/WO2013082429A1/en active Application Filing
- 2012-11-30 MX MX2014006514A patent/MX354955B/es active IP Right Grant
-
2013
- 2013-10-17 US US14/056,702 patent/US9150550B2/en active Active
-
2015
- 2015-04-07 HK HK15103396.7A patent/HK1202866A1/xx unknown
- 2015-08-25 US US14/834,836 patent/US9790204B2/en active Active
-
2017
- 2017-09-12 US US15/702,427 patent/US10647696B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2648340T3 (es) | 2018-01-02 |
| US9790204B2 (en) | 2017-10-17 |
| WO2013082429A1 (en) | 2013-06-06 |
| EP2785710B1 (en) | 2017-09-20 |
| CN103974950A (zh) | 2014-08-06 |
| KR102031846B1 (ko) | 2019-10-14 |
| HK1202866A1 (en) | 2015-10-09 |
| US20180127395A1 (en) | 2018-05-10 |
| CN103974950B (zh) | 2016-12-21 |
| CA2856831C (en) | 2020-02-18 |
| KR20140097552A (ko) | 2014-08-06 |
| JP6141863B2 (ja) | 2017-06-07 |
| JP2015500240A (ja) | 2015-01-05 |
| US10647696B2 (en) | 2020-05-12 |
| US20160185756A1 (en) | 2016-06-30 |
| US20140121195A1 (en) | 2014-05-01 |
| US9150550B2 (en) | 2015-10-06 |
| MX2014006514A (es) | 2014-07-10 |
| AU2012345779A1 (en) | 2014-06-12 |
| US8685959B2 (en) | 2014-04-01 |
| US20130165423A1 (en) | 2013-06-27 |
| AU2012345779B2 (en) | 2017-04-06 |
| CA2856831A1 (en) | 2013-06-06 |
| MX354955B (es) | 2018-03-27 |
| BR112014013150A2 (pt) | 2017-06-13 |
| EP2785710A1 (en) | 2014-10-08 |
| DK2785710T3 (en) | 2017-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1202866A1 (en) | Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists ccr(4) | |
| AP3862A (en) | Novel benzimidazole derivatives as ep4 antagonists | |
| HK1211599A1 (en) | Il-6 antagonists and uses thereof il-6 | |
| PL2585064T3 (pl) | Antagoniści C5AR | |
| EP2751135A4 (en) | VEGF SPECIFIC CAPTURING AGENTS, COMPOSITIONS CONTAINING SAME AND METHODS OF USE AND PRODUCTION THEREOF | |
| HK1195068A1 (zh) | 拮抗劑 | |
| EP2709991A4 (en) | USE OF CXCR4 ANTAGONISTS | |
| HK1202867A1 (en) | Substituted anilines as ccr(4) antagonists ccr(4) | |
| EP2720546A4 (en) | TRPV4 Antagonist | |
| PL2736918T3 (pl) | Antagoniści progesteronu | |
| EP2558122A4 (en) | COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS | |
| EP2720697A4 (en) | TRPV4 Antagonist | |
| EP2549872A4 (en) | TRPV4 Antagonist | |
| EP2668044A4 (en) | COMPOSITIONS AND THEIR USE | |
| HK1210783A1 (en) | Octahydro-cyclopentapyrrolyl antagonists of ccr2 ccr2 | |
| SI2882715T1 (sl) | Derivati pirazola in njihova uporaba kot antagonisti LPAR5 | |
| IL238461A0 (en) | 1 hindole-3-carboxamide derivatives and their use as p2y12 inhibitors | |
| EP2776064A4 (en) | ANTAGONISTS OF PRO-VASOPRESSIN AND USES THEREOF | |
| EP2729184A4 (en) | NEW AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIAN SYSTEM | |
| PT2709991T (pt) | Uso de antagonistas de cxcr4 para tratar síndrome de whim, mielocatexia, neutropenia e linfocitopenia |